Pages that link to "Q37832570"
Jump to navigation
Jump to search
The following pages link to Allogeneic stem cell transplantation for chronic lymphocytic leukemia: Lessons to be learned from minimal residual disease studies (Q37832570):
Displaying 19 items.
- High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment (Q31043227) (← links)
- In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice (Q34541243) (← links)
- Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies? (Q34625543) (← links)
- Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents? (Q34769213) (← links)
- Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells (Q36777093) (← links)
- Practical approach to management of chronic lymphocytic leukemia (Q36845277) (← links)
- Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. (Q37087424) (← links)
- New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation (Q37344050) (← links)
- Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells. (Q39197427) (← links)
- Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study (Q39996013) (← links)
- Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia (Q40429099) (← links)
- Challenges for the next decade: allogeneic stem cell transplantation in chronic lymphocytic leukemia (Q40817438) (← links)
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia (Q41429394) (← links)
- Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons. (Q42378526) (← links)
- Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma (Q43444250) (← links)
- Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma (Q47603352) (← links)
- Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal? (Q90292627) (← links)
- Is chronic lymphocytic leukemia curable? A clinical case relapsing 21 years after allogeneic stem-cell transplantation (Q90590377) (← links)
- The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice (Q91786165) (← links)